ReviewCurrent oncology reports2024

Sodium-Glucose Cotransporter 2 Inhibitors During Cancer Therapy: Benefits, Risks, and Ongoing Clinical Trials.

Nichanan Osataphan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.